Evaluating heart health in beta thalassemia patients using echocardiograms
Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram
Nanfang Hospital, Southern Medical University · NCT04929574
This study is testing how the amount of iron in the hearts of people with beta thalassemia affects their heart health using echocardiograms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Sex | All |
| Sponsor | Nanfang Hospital, Southern Medical University (other) |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT04929574 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the heart status of patients diagnosed with beta thalassemia through the use of echocardiograms. It focuses on understanding the impact of myocardial iron deposition, a serious complication in transfusion-dependent beta thalassemia, on cardiac function. By analyzing echocardiographic data, the study seeks to correlate the severity of cardiac dysfunction with the amount of iron deposited in the heart. The research is conducted in southern China, involving multiple hospitals affiliated with Southern Medical University.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with beta thalassemia.
Not a fit: Patients with iron deficiency anemia will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management of heart complications in beta thalassemia patients.
How similar studies have performed: Other studies have shown the importance of echocardiograms in assessing heart health in similar patient populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with beta-thalassemia Exclusion Criteria: * Iron deficiency anemia
Where this trial is running
Guangzhou, Guangdong
- Southern Medical University — Guangzhou, Guangdong, China (RECRUITING)
Study contacts
- Study coordinator: Xiangmin Xu, Prof. Dr.
- Email: xixm@smu.edu.cn
- Phone: (20) 61648293
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Beta Thalassemia